about
HSulf-1 inhibits angiogenesis and tumorigenesis in vivoA role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformationTCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathwayHSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cellsSerine protease HtrA1 modulates chemotherapy-induced cytotoxicityA candidate tumor suppressor HtrA1 is downregulated in ovarian cancerClinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C statusHighly parallel genome-wide expression analysis of single mammalian cellsIdentification of tubulins as substrates of serine protease HtrA1 by mixture-based oriented peptide library screening.The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.digit-a tool for detection and identification of genomic interchromosomal translocationsHtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation.Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancerFusionHunter: identifying fusion transcripts in cancer using paired-end RNA-seq.Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.Expression and functional significance of HtrA1 loss in endometrial cancerTargeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cellsAssessment of hepatocyte growth factor in ovarian cancer mortality.Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case.Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples.TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancerExpression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionNeonatal Progesterone Programs Adult Uterine Responses to Progesterone and Susceptibility to Uterine DysfunctionComplete Transcriptome RNA-Seq.Metformin intake is associated with better survival in ovarian cancer: a case-control studyMolecular pathogenesis and therapeutic targets in epithelial ovarian cancer.Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment.Serine protease HtrA1 associates with microtubules and inhibits cell migration.The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.HtrA serine proteases as potential therapeutic targets in cancer.Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary.Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
P50
Q24293660-A344323C-1536-4FD0-B43D-CFE96C9D590BQ24314746-346942ED-34C3-4308-8D37-017810A2448AQ24336598-8102294D-C84A-4347-BA03-00C94637A4FDQ24338405-DB235A22-0A64-462C-AC09-DD3A1E309C49Q24547477-693B90E2-F375-45BB-9524-769B698F3021Q28238155-9B56DF72-3805-411E-ABDE-4581A4739FDDQ28307436-D981C6C1-F3B6-41EE-A80B-37DDEC02C11EQ28732185-CD086524-780A-44DC-88B3-D030C9256C65Q33419954-9AA933C2-5C81-45B0-8351-F98C49030B33Q33638726-7533EE3F-0072-452E-8259-CFC68CDE87A8Q33701551-E67B0023-A921-47BD-BD43-9636A0776B49Q33841141-1DF4F236-77E5-4089-8620-92812B317AAEQ34182618-AF79A026-1B81-4C20-BB21-A49B7B8ED1ACQ34183040-504401AC-7E76-441A-A872-92F73EEC8F18Q34189632-2A38EE88-75C7-49AA-97D2-1865A4E82679Q34286925-E5464CC9-B156-4B8B-9499-FCE14F2CBA8DQ34299789-33A492B0-1C4F-4297-8148-CD40B6D722A8Q34575452-2DBF55F9-373C-4954-AD92-59F28415CD9FQ34649455-BFABB4C4-244C-4A5E-9CE4-74C18F6EA831Q34674552-057E31CE-115D-4436-8746-05E1E7CE1E7CQ34956879-5228F154-BBE9-4079-A07C-3EFB6B37D516Q35156876-D610C988-B3B4-43BE-9A30-65AC36DFEBB3Q35837219-46604881-0AF4-4E48-A1F6-0A6928376896Q35877153-E695661F-D0FD-4465-8629-72E926DE5706Q35881001-F621DB6B-18BD-4921-9D43-2D5C13D26A2CQ35961836-D4E2760C-9AE2-405F-88E9-122ADEE04F5AQ36071154-EA0429EE-452C-4744-806F-0261F47D9E1AQ36107514-AF3A97CC-C4FA-4B3B-9D57-1D8106347E09Q36180848-031582DF-8552-4D16-A60E-9966C2FC82CFQ36557010-F8351BF1-4C6F-4FEC-92DA-27581892BE4FQ36945763-2D029514-7B81-46CE-9E1D-6A3D7D3B8E2FQ37193053-DF85AB53-5202-4E8B-8A41-DF7C89B4B0D7Q37275172-F049FF25-4FBD-4588-8F1F-66AA7A0E2A54Q37317206-520F214A-FF61-465A-A42E-A751AF48A298Q37402303-F987A0A1-F960-48DE-92E0-AA1239385362Q37515512-1C922B94-9A1C-406E-97F2-1CE23E7101D4Q37562866-5EDF84AC-037A-4F3E-8A16-555420179D4FQ37661132-593EA496-4B4C-4E54-ABC1-C6DF68110D3EQ38303667-1F08C5C7-5F23-47AB-BA94-F473CAF41FC3Q38384791-BDDAA952-873A-479B-9705-ADB43EBBB026
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jeremy Chien
@ast
Jeremy Chien
@en
Jeremy Chien
@es
Jeremy Chien
@nl
Jeremy Chien
@sl
type
label
Jeremy Chien
@ast
Jeremy Chien
@en
Jeremy Chien
@es
Jeremy Chien
@nl
Jeremy Chien
@sl
prefLabel
Jeremy Chien
@ast
Jeremy Chien
@en
Jeremy Chien
@es
Jeremy Chien
@nl
Jeremy Chien
@sl
P108
P106
P1153
7202435241
P21
P2798
P31
P496
0000-0003-4744-8374